Normal view MARC view ISBD view

Challenges and opportunities in drug development for nonalcoholic steatohepatitis.

Ocker, Matthias

Challenges and opportunities in drug development for nonalcoholic steatohepatitis. [electronic resource] - European journal of pharmacology Mar 2020 - 172913 p. digital

Publication Type: Journal Article; Review

ISSN: 1879-0712

Standard No.: 10.1016/j.ejphar.2020.172913 doi

Subjects--Topical Terms:
Animals
Biomarkers
Disease Progression
Drug Development
Fibrosis--complications
Humans
Incidence
Inflammation--complications
Liver--metabolism
Liver Neoplasms--complications
Metabolic Diseases--complications
Non-alcoholic Fatty Liver Disease--drug therapy
Prevalence
Severity of Illness Index
Treatment Outcome

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)